AccuStem Sciences, Inc. Announces Chairman Purchase of
LONDON and PHOENIX, April 28, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for...
Stay updated with breaking news from Stem Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON and PHOENIX, April 28, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for...
Investegate announcements from AccuStem Sciences, Inc, AccuStem Sciences, Inc. Announces DTC Eligibility
LONDON and PHOENIX, April 14, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, is pleased to announce its
LONDON and PHOENIX, April 05, 2022 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTC Pink: ACUT), a life sciences company dedicated to improving outcomes for patients with cancer, announced that it has
Investegate announcements from AccuStem Sciences, Inc, AccuStem Announces Private Placement of Common Stock